Global Nuclear Medicine/Radiopharmaceuticals Market 2018-2023: Major Players are Cardinal Health, GE Healthcare, and Curium
Summary
The major influencing factors driving the growth of this market are the increasing incidence and prevalence of target conditions and initiatives to lessen the demand-supply gap of Mo-99.Tc-99m accounted for the largest number of procedures performed in the nuclear medicine market as it has a longer half-life and is easy to transport as compared to other radiopharmaceuticals.By region, the global market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.The Asia Pacific market is expected to grow at the highest CAGR during the forecast period.Factors such as short half-life of radiopharmaceuticals, hospital budget cuts, and high equipment prices are expected to limit the growth of the market to a certain extent.
Classifications
AskAI Classifications
LabelsLinked Companies
